Affiliation:
1. Regional State budgetary institution health Usolskaja hospital; Irkutsk State Medical Academy of Postgraduate Education — Branch Campus of the Russian Medical Academy of Continuing Professional Education
Abstract
Aim: Evaluate the relationship of Smoking with fatty liver disease (FLD) of various etiologies.Materials and Methods: Out of1568 residents of the rural therapeutic area agreed to participate in the study of 1123 residents of the rural medical area with negative markers of hepatitis B and / or C. The survey included the collection of anamnesis for smoking and alcohol consumption. An objective, laboratory (complete blood count, biochemical liver function tests) and instrumental examination, including ultrasound examination of the abdominal organs, were carried out.Results: Non-alcoholic fatty liver disease (NAFLD) was detected in 247 (22.0%) people, alcoholic liver disease (ALD) — in 276 (24.6%) (p>0.05). 542 people smoked of the surveyed. Among patients with NAFLD, Smoking was 20.2%, their Smoking experience was 35.1±11.5 years, and the Smoking index was 24.5±10.9. Among patients with ALP, Smoking is higher-93.1% (p<0.05), Smoking experience is less — 29.5±9.8 years (p<0.05), as is the Smoking index of 21.8±7.7 (p<0.05). Among smokers, 56.8% had FLD, 83.8% of them were of alcoholic etiology, and 16.2% were non — alcoholic (p<0.05). Among non-smokers, compared with smokers, FLD was detected less frequently — in 37.2% of people (p<0.05), of which alcohol etiology — in 8.8% (p<0.05), non — alcoholic-in 91.2% (p<0.05).Conclusion: In the rural therapeutic area, 93.1% of ALD sufferers smoke, and 20.2% of NAFLD patients smoke (p<0.05). In patients with NAFLD, the duration of smoking was longer (35.1 ± 11.5) than in patients with ALD — 29.5 ± 9.8 years (p <0.05); the smoking index was 24.5 ± 10.9 and 21.8 ± 7.7 pack-years (p<0.05), respectively. In smokers, FLD was more common (56.8%) than in non-smokers (37.2%) (p<0.05). FLD in smokers was of alcoholic etiology more often (83.8%) than non-alcoholic (16.2%) (p<0.05), in non-smokers non-alcoholic etiology prevailed (91.2%) (p<0.05).
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference13 articles.
1. WHO global report on trends in prevalence of tobacco smoking 2000-2025 - Second edition. World Health Organization. Geneva. Available: https://whodc.mednet.ru/ru/osnovnye-publikaczii/borba-s-tabakom/2890/visit.html?link_name=apps.who.int%2Firis%2Fbit-stream%2Fhandle%2F10665%2F272694%2F978924151 4170-eng.pdf (Access: 04.05.2020.)
2. Ivashkin V.T., Drapkina O. M., Mayev I. V., et al. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015; 6: 31-41. (in Russ.)
3. Akhavan Rezayat A., Dadgar Moghadam M., Ghasemi Nour M., et al. Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis. SAGE Open Med. 2018 Jan 24;6: 2050312117745223. doi: 10.1177/2050312117745223. PMID: 29399359; PMCID: PMC5788091.
4. Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F. The Lifestyle Characteristics in Non-Alcoholic Fatty Liver Disease in the PERSIAN Guilan Cohort Study. Open Access Maced J Med Sci. 2019 Sep 14;7(19):3313-3318. doi: 10.3889/oamjms.2019.647. PMID: 31949537; PMCID: PMC6953935.
5. Bayerl C., Lorbeer R., Heier M., et al. Alcohol consumption, but not smoking is associated with higher MR-derived liver fat in an asymptomatic study population. PLoS One. 2018 Feb 5;13(2): e0192448. doi: 10.1371/journal.pone.0192448. PMID: 29401483; PMCID: PMC5798849.